Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial.
Hengstenberg C, Chandrasekhar J, Sartori S, Lefevre T, Mikhail G, Meneveau N, Tron C, Jeger R, Kupatt C, Vogel B, Farhan S, Sorrentino S, Sharma M, Snyder C, Husser O, Boekstegers P, Hambrecht R, Widder J, Hildick-Smith D, De Carlo M, Wijngaard P, Deliargyris E, Bernstein D, Baber U, Mehran R, Anthopoulos P, Dangas G; BRAVO-3 Investigators. Hengstenberg C, et al. Among authors: widder j. Catheter Cardiovasc Interv. 2017 Nov 15;90(6):1027-1037. doi: 10.1002/ccd.27155. Epub 2017 Jun 20. Catheter Cardiovasc Interv. 2017. PMID: 28493641 Clinical Trial.
Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement.
Sinning JM, Wollert KC, Sedaghat A, Widera C, Radermacher MC, Descoups C, Hammerstingl C, Weber M, Stundl A, Ghanem A, Widder J, Vasa-Nicotera M, Mellert F, Schiller W, Bauersachs J, Zur B, Holdenrieder S, Welz A, Grube E, Pencina MJ, Nickenig G, Werner N, Kempf T. Sinning JM, et al. Among authors: widder j. Am Heart J. 2015 Oct;170(4):821-9. doi: 10.1016/j.ahj.2015.07.003. Epub 2015 Jul 10. Am Heart J. 2015. PMID: 26386807 Free article.
Sex-based differences in outcomes with bivalirudin or unfractionated heparin for transcatheter aortic valve replacement: Results from the BRAVO-3 randomized trial.
Asgar A, Chandrasekhar J, Mikhail G, Webb J, Lefèvre T, Tamburino C, Hildick-Smith D, Hambrecht R, Van Belle E, Widder J, Dumonteil N, Hink U, Jeger R, Linke A, Deliargyris E, Gao P, Mehran R, Hengstenberg C, Anthopoulos P, Dangas G; BRAVO-3 Investigators. Asgar A, et al. Among authors: widder j. Catheter Cardiovasc Interv. 2017 Jan;89(1):144-153. doi: 10.1002/ccd.26607. Epub 2016 Aug 16. Catheter Cardiovasc Interv. 2017. PMID: 27152677
Impact of diabetes mellitus on short term vascular complications after TAVR: Results from the BRAVO-3 randomized trial.
Goel R, Power D, Tchetche D, Chandiramani R, Guedeney P, Claessen BE, Sartori S, Cao D, Meneveau N, Tron C, Dumonteil N, Widder JD, Hengstenberg C, Ferrari M, Violini R, Stella PR, Jeger R, Anthopoulos P, Deliargyris EN, Mehran R, Dangas GD. Goel R, et al. Int J Cardiol. 2019 Dec 15;297:22-29. doi: 10.1016/j.ijcard.2019.09.063. Epub 2019 Oct 11. Int J Cardiol. 2019. PMID: 31630816 Clinical Trial.
Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trial.
Razuk V, Camaj A, Cao D, Nicolas J, Hengstenberg C, Sartori S, Zhang Z, Power D, Beerkens F, Chiarito M, Meneveau N, Tron C, Dumonteil N, Widder JD, Ferrari M, Violini R, Stella PR, Jeger R, Anthopoulos P, Mehran R, Dangas GD. Razuk V, et al. Among authors: widder jd. Catheter Cardiovasc Interv. 2021 Nov 15;98(6):E870-E880. doi: 10.1002/ccd.29753. Epub 2021 May 12. Catheter Cardiovasc Interv. 2021. PMID: 33909348 Clinical Trial.
Multicenter comparison of latest-generation balloon-expandable versus self-expanding transcatheter heart valves: Ultra versus Evolut.
Rheude T, Pellegrini C, Allali A, Bleiziffer S, Kim WK, Neuser J, Landt M, Rudolph T, Renker M, Widder JD, Qu L, Alvarez-Covarrubias HA, Mayr NP, Richardt G, Xhepa E, Joner M. Rheude T, et al. Among authors: widder jd. Int J Cardiol. 2022 Jun 15;357:115-120. doi: 10.1016/j.ijcard.2022.03.043. Epub 2022 Mar 22. Int J Cardiol. 2022. PMID: 35337936
Mitochondrial thioredoxin reductase is essential for early postischemic myocardial protection.
Horstkotte J, Perisic T, Schneider M, Lange P, Schroeder M, Kiermayer C, Hinkel R, Ziegler T, Mandal PK, David R, Schulz S, Schmitt S, Widder J, Sinowatz F, Becker BF, Bauersachs J, Naebauer M, Franz WM, Jeremias I, Brielmeier M, Zischka H, Conrad M, Kupatt C. Horstkotte J, et al. Among authors: widder j. Circulation. 2011 Dec 20;124(25):2892-902. doi: 10.1161/CIRCULATIONAHA.111.059253. Epub 2011 Dec 5. Circulation. 2011. PMID: 22144571
200 results